Skip to main content

Table 7 EORTC prostate cancer module (QLQ-PR25) at timepoint of evaluation [Mean 3.2 (SD: 2.8) years after end of radiotherapy]

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

PR25 functional scores

Value (mean/± SD/median)

Sexual activity (PRSAC-score)

36.8/29.4/33.3

Sexual functioning (PRSFU-score)

47.2/25.4/33.3

PR25 Symptom scores

Value (mean/± SD/median)

Urinary symptoms (PRURI-score)

24.9/20.8/19.5

Bowel symptoms (PRBOWE-score)

6.6/9.2/0.0

Hormonal treatment-related symptoms (PRHTR-score)

18.0/14.9/16.7

Incontinence aid (PRAID-score)

24.6/32.2/0.0